Arizona scientists believe a more contagious variant of the new coronavirus may already be in Arizona and the state must intensify its efforts to monitor for new strains and mutations. The vaccine rollout continues as hospital leaders warn about strained resources. Arizona’s three public universities are continuing to test wastewater for COVID-19 while the University of Arizona College of Medicine-Phoenix is seeing a spike in applications for the next academic year, which is being attributed to the pandemic.
ASU researchers say COVID-19 will soon be leading cause of death in Arizona / azfamily.com
Valley hospital leaders show solidarity, sound alarm on COVID surge / ABC 15
Valley hospital leaders warn they’re getting closer to implementing triage standards of care / 12 News
Arizona likely has U.K. coronavirus strain, but South Africa variant is a greater concern / Arizona Republic
Here’s what we know so far about the UK variant strain of COVID-19 in Arizona / Arizona Republic
It’s in the wastewater: How Arizona universities are testing for COVID-19 / Arizona Republic
ASU vaccine expert explains what we know about current coronavirus vaccines / KJZZ
Vaccines expected to begin rolling out to Arizona assisted-living facilities on Monday / Arizona Republic
From deep-freeze to the frontline; a look at COVID-19 vaccine dose preparation / ABC 15
Arizona opens 24/7 COVID-19 vaccination site at State Farm Stadium in Glendale / Arizona Republic
Coconino County COVID-19 vaccines expand to education workers, first responders, elderly / Arizona Daily Sun
Fauci Effect: Med school applications way up at University of Arizona College of Medicine-Phoenix / KJZZ
Arizona colleges, universities starting spring semester with more online classes, COVID-19 testing / KJZZ
Months later, St. Luke’s Medical Center in Phoenix remains on standby / ABC 15
Holes in health safety net leave U.S., Arizona vulnerable to pandemics / KJZZ
Phoenix nonprofit TGEN signs deal to expand cancer detection via blood test / Arizona Republic
Translational Genomics Research Institute has licensed a blood-biopsy method to test for cancer to a Wisconsin-based company to expand reach of the technology—the organization’s largest licensing deal since its founding in 2002.
Upcoming Events
Jan. 19: AZBioPEERS (R&D Tax Credits)
Jan. 21: reimagine Health Research Symposium
Jan 30: Connect2STEM 2021
Feb. 2: BIO5 Inspiring Women in STEM